Biotechnology
New patent expiration for Eisai Inc BANZEL drug – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published on new patent expiration for Eisai Inc’s BANZEL drug
Annual Drug Patent Expiration for BANZEL
Banzel is a drug marketed by Eisai Inc and included in two NDAs. It is available from a single supplier. There is one patent protecting this drug and two Paragraph IV challenges.
BANZEL drug price trends.
Drug patent litigation for BANZEL.
The generic ingredient in BANZEL is rufinamide. One registered supplier for this compound. Additional details are available on the rufinamide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published on new patent expiration for Eisai Inc’s BANZEL drug
